National-Oilwell (NOV) 54.78 $NOV Dividend Growth

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
National-Oilwell (NOV) 54.78 $NOV

Dividend Growth Checkup
Passive Income Pursuit - at Seeking Alpha - Tue Mar 03, 8:39PM CST

KO: 42.50 (-0.45), NOV: 54.78 (+0.34), SBUX: 93.06 (-0.94), KMI: 41.04 (-0.05), JNJ: 101.65 (-0.69), T: 34.00 (-0.41), PSX: 77.96 (-0.13), V: 273.75 (-1.55), XOM: 87.18 (-0.44), VZ: 49.07 (-0.48)

Watch for National Oilwell Varco to Potentially Pullback After Gaining 2.65% Yesterday
Comtex SmarTrend(R) - Mon Mar 02, 3:54PM CST
National Oilwell Varco (NYSE:NOV) traded in a range yesterday that spanned from a low of $53.90 to a high of $55.82. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $55.00 on volume of 9.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NOV: 54.78 (+0.34)

Look for Shares of National Oilwell Varco to Potentially Pullback after Yesterday's 2.65% Rise
Comtex SmarTrend(R) - Mon Mar 02, 3:54PM CST
National Oilwell Varco (NYSE:NOV) traded in a range yesterday that spanned from a low of $53.90 to a high of $55.82. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $55.00 on volume of 9.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NOV: 54.78 (+0.34)

National Oilwell Varco (NOV) Approaches New Upside Target of $55.31
Comtex SmarTrend(R) - Mon Mar 02, 12:22PM CST
Shares of National Oilwell Varco (NYSE:NOV) have bullishly opened above the pivot of $54.02 today and have reached the first resistance level of $54.83. Should the shares continue to rise, the resistance pivots of $55.31 and $56.60 will be of interest.
NOV: 54.78 (+0.34)

National Oilwell Varco's board sets dividend payment date of 27 March 2015
M2 - Mon Mar 02, 6:11AM CST
The board of directors of National Oilwell Varco (NYSE:NOV), an oilfield company, on Friday declared its quarterly dividend of USD0.46 per share of its common stock.
NOV: 54.78 (+0.34)

Freedom Fund Update - March 2015
Dividend Mantra - Seeking Alpha - Mon Mar 02, 5:35AM CST
Well, the time has come to update the Freedom Fund once again as we start another month. The Freedom Fund is my portfolio, and I think it's aptly named. My portfolio is my way to freedom; freedom from a job I don't desire, to purchase goods I don't...
NOV: 54.78 (+0.34), MDT: 78.19 (+0.16), OHI: 40.11 (-0.15), O: 50.34 (-0.21)

Continue To Ignore National Oilwell Varco
Abba's Aces - at Seeking Alpha - Sun Mar 01, 11:16PM CST

NOV: 54.78 (+0.34)

National Oilwell Varco - Standing Strong In The Midst Of The Storm
Marko Mircetic - at Seeking Alpha - Sun Mar 01, 8:10AM CST
Backlog National Oilwell Varco (NYSE: NOV ) is entering 2015 on the wings of yet another strong year and a solid backlog of $12.85 billion from the Rig Systems segment and $1.8 billion from the Completion & Production segment. The management...
NOV: 54.78 (+0.34)

Tesco Corporation: Potential Double In 1-2 Years Caused By Current Economic Environment
Nicholas Bodnar - at Seeking Alpha - Sat Feb 28, 10:08AM CST

NOV: 54.78 (+0.34), TESO: 10.78 (+0.21)

5 Stocks Warren Buffett Is Selling: Exxon, ConocoPhillips and More
at The Street - Sat Feb 28, 10:04AM CST
Buffett's Berkshire Hathaway trimmed its positions in these stocks in the most recently reported quarter.
NOV: 54.78 (+0.34), ESRX: 84.83 (+0.48), XOM: 87.18 (-0.44), COP: 64.25 (-0.53), BK: 39.44 (-0.21)

The Best All-Around Stock in the Market
Matthew Frankel, The Motley Fool - Motley Fool - Fri Feb 27, 8:05AM CST
What are the best stocks to buy right now? Maybe you should buy financials like Wells Fargo as a play on the continued economic recovery, or oil companies like ExxonMobil while prices remain depressed. Or maybe your money should be used to buy...
KO: 42.50 (-0.45), PSX: 77.96 (-0.13), GE: 25.66 (-0.20), AXP: 80.63 (-1.28), XOM: 87.18 (-0.44), WMT: 82.58 (-0.79), COP: 64.25 (-0.53), WFC: 54.82 (-0.63), UPS: 100.42 (-1.08), NOV: 54.78 (+0.34), JNJ: 101.65 (-0.69), V: 273.75 (-1.55), GS: 189.67 (-1.60), USB: 44.41 (-0.34), IBM: 159.42 (-1.61), COST: 147.17 (-0.20), GM: 37.57 (-0.23), PG: 84.35 (-0.81), VZ: 49.07 (-0.48), MA: 91.71 (+0.74)

National Oilwell Varco declares $0.46 dividend
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 6:57AM CST

NOV: 54.78 (+0.34)

Oilfield services gains won't hold up as U.S. storage fills, Credit Suisse says
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 5:38PM CST

NOV: 54.78 (+0.34), OIS: 43.51 (-0.27), CAM: 48.10 (+1.87), OIH: 34.97 (+0.06), HLX: 14.29 (-0.51), HAL: 43.07 (-0.04), DRQ: 75.25 (+1.76), FTI: 39.50 (-0.12), FET: 19.71 (+0.34), SPN: 22.42 (+0.40), SLB: 85.14 (+0.23), BHI: 62.46 (-0.19)

Billionaire Investors Are Piling Into These 14 Dividend Stocks
at The Street - Thu Feb 26, 7:00AM CST
Looking for dividend stock ideas? Here are 14 ideas from billionaires ranging from Warren Buffett to Ray Dalio.
TERP: 34.25 (unch), PCG: 53.63 (-0.08), GME: 40.03 (+1.35), FCX: 20.87 (-0.12), KMB: 108.37 (-1.89), KRFT: 63.18 (-0.60), NRZ: 15.36 (+0.20), NOV: 54.78 (+0.34), ETR: 76.50 (-0.98), RDS.A: 62.92 (-0.38), RIG: 16.60 (+0.09), FSC: 7.22 (+0.05), VALE: 6.88 (-0.25), SUNE: 22.40 (-0.34), AEO: 15.96 (+1.14), MRK: 57.88 (-0.46), PG: 84.35 (-0.81), CAT: 81.73 (-1.11), VNR: 16.63 (-0.31)

How To Play An Oil Services Rebound
Frank Isaksen, CFA - at Seeking Alpha - Tue Feb 24, 10:48AM CST

NOV: 54.78 (+0.34), USO: 19.01 (+0.52), SPY: 210.23 (-0.89), OIH: 34.97 (+0.06), HAL: 43.07 (-0.04), SLB: 85.14 (+0.23)

Consumer discretionary and tech popular as iBillionaire rebalances
Seeking Alpha - at Seeking Alpha - Mon Feb 23, 11:07AM CST

CCI: 85.82 (-0.48), CNX: 30.29 (-1.49), C: 53.67 (-0.06), HAL: 43.07 (-0.04), AMGN: 159.19 (+0.63), KORS: 67.14 (-1.20), AET: 101.75 (+1.96), GOOG: 573.37 (-0.27), PVH: 105.76 (-0.07), HUM: 160.22 (-0.03), TWX: 83.08 (-0.08), NOV: 54.78 (+0.34), AGN: 235.68 (+0.82), YHOO: 43.99 (+1.37), HCA: 74.93 (+4.14), GT: 26.57 (-0.50), THC: 49.99 (+2.93), MHK: 185.03 (-0.56), IBLN: 26.35 (-0.07), ABBV: 60.27 (+0.65), EMC: 28.20 (-0.19), GOOGL: 578.33 (-0.46), CBS: 62.46 (-0.34)

3 Great Energy Stocks We're Buying Now
Tyler Crowe, Jason Hall, and Matt DiLallo, The Motley Fool - Motley Fool - Sat Feb 21, 10:38AM CST
We get it, oil prices are down more than 50% over the past seven months, which scares the bejesus out of investors who have any exposure to energy stocks. However, this doesn't mean you should be selling out of the energy sector. In fact, buying...
NOV: 54.78 (+0.34), PSX: 77.96 (-0.13), CLB: 111.91 (+1.71)

Buffett’s Berkshire Hathaway Sells Exxon, ConocoPhilips, Buys Deere, IBM
at The Street - Wed Feb 18, 3:04PM CST
Famed investor Warren Buffett increased his Berkshire Hathaway positions in IBM and Deere, while liquidating positions in Exxon Mobil, ConocoPhillips and Express Scripts.
SU: 30.14 (+0.02), NOV: 54.78 (+0.34), QSR: 42.54 (-1.08), ESRX: 84.83 (+0.48), IBM: 159.42 (-1.61), FOXA: 34.97 (-0.67), DE: 90.45 (-0.82), XOM: 87.18 (-0.44), COP: 64.25 (-0.53), BRK.B: 144.92 (-1.01), BRK.A: 217,612.00 (-1,388.00)

Why I’m Not Ready to Buy National Oilwell Varco Inc.’s Stock Just Yet
Matt DiLallo, The Motley Fool - Motley Fool - Wed Feb 18, 1:00PM CST
National Oilwell Varco builds and sells the equipment that makes oil and gas drilling possible. Because of that its business is tied to the rise and fall of energy prices as those prices dictate future activity leading to more, or less, business...
NOV: 54.78 (+0.34)

National Oilwell Varco's Management Needs You to Know This About Falling Oil Prices
Tyler Crowe, The Motley Fool - Motley Fool - Wed Feb 18, 11:45AM CST
National Oilwell Varco has been around for more than 150 years, so it has seen its fair share of oil price spikes and plunges. This one is really no different than the ones the company has dealt with before, and according to the company's most...
NOV: 54.78 (+0.34)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 4

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 5

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 3

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 6

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading

Top 5 Most Recently Viewed Articles

Bitcoin's Path to $100,000: Expert Insights and Predictions

Updated Category News Views 115

Bitcoin's Potential Surge Towards $100,000 Crypto analyst Trader Mayne has recently suggested that Bitcoin could be preparing for one final push toward the impressive milestone of $100,000. He notes, however, that the overall market cycle resembles a prolonged five-year super cycle, which may culminate in a significant downturn in the near future. Current Market...

Continue Reading
Executive Leadership Shift at Geisinger with Dr. Mitchell

Updated Category News Views 755

Geisinger Appoints Jason W. Mitchell, M.D. as CMO In a notable leadership transition, Geisinger has officially announced the appointment of Jason W. Mitchell, M.D. as its executive vice president and chief medical officer. This decision comes after an exhaustive search aimed at finding a leader with the vision and expertise to guide the organization into its next chapter....

Continue Reading
What Investors Should Expect from Euroseas Earnings Release

Updated Category News Views 131

Insights Ahead of Euroseas's Earnings Report Euroseas (NASDAQ:ESEA) is gearing up to unveil its latest quarterly earnings, a moment that investors eagerly anticipate. This report holds substantial importance, as it can influence both investor sentiment and stock performance significantly. What Analysts Are Predicting Leading up to the earnings announcement, analysts...

Continue Reading
Establishing Strategic Ties: AEGGIS Summit Focus on Growth

Updated Category News Views 237

Atlantic Council and Antenna Group Unite for AEGGIS The Atlantic Council and Antenna Group have unveiled an exciting initiative known as the Alliance for Europe–Gulf Geopolitics & Investments Summit (AEGGIS). This summit is poised to play a pivotal role in strengthening the economic connections between European and Gulf nations. A Platform for Engagement and Dialogue...

Continue Reading
China Pharma Closes $5M Offering: What Lies Ahead?

Updated Category News Views 14

China Pharma's $5 Million Secured: A Strategic Move? Tough out there in the pharma jungle, isn't it? China Pharma Holdings, Inc. (NYSE American: CPHI) just wrapped up a neat $5 million direct offering. With each of their 2.5 million shares going for two bucks a pop, they're setting sails in a tumultuous sea. Now, why does this matter? Well, cash moshes in the pharma pit...

Continue Reading